Presentations will feature potential best-in-class pan-RAS molecular glue ERAS-0015 and pan-KRAS inhibitor ERAS-4001Erasca will also present ...

Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class i targeted and immune-mediated therapeutics to fight cancer, today announced that an ...

Following the formal business and voting portion of the Meeting, Anixa Chairman and CEO Dr. Amit Kumar, will deliver an investor presentation and corporate update, followed by a question-and ...

March 10, 2025 — AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company today announces the publication of two abstracts submitted to The Association for Research in Vision and ...

Kent County Levy Court officials are apologizing after pornography was shared during a presentation at a Regional Planning Commission meeting Thursday. The levy court uses Webex, a Zoom-like ...

at the upcoming American Academy of Neurology 2025 annual meeting in San Diego, California, from April 5 to April 9. The presentations will cover various studies related to BRIUMVI in patients ...

today announced that three abstracts on its investigational gene therapy candidates have been accepted for presentation at the Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting, ...

2025 Annual Meeting to be held in Orlando, Florida from March 7-11, 2025. AD, a chronic, heterogeneous, inflammatory disease characterized by skin redness, pruritus, and pain, is driven by skin ...

Availability of Information on Alto’s Website Alto routinely uses its investor relations website to post presentations to investors and other important information, including information that ...

Ltd., the asset management company of the 3D OPPORTUNITY MASTER FUND (collectively referred to as “3D,” “we” or “our”), today released a presentation regarding a shareholder proposal ...

today announced five poster presentations and an oral presentation of briquilimab data at the AAAAI 2025 Annual Meeting, being held February 28 - March 3, 2025, in San Diego, CA. The oral ...

This travel ban affected all NIH-sponsored travel, including for professional meetings and conferences where many scientists were due to make presentations. But some grant-review meetings ...